Treatment of Neonatal Jaundice from Rh Hemolytic Disease
Introduction to Phototherapy
- The American Academy of Pediatrics recommends intensive phototherapy as the primary treatment for neonatal jaundice due to Rh incompatibility, using blue LED lights (460-490 nm) at irradiance ≥30 μW·cm⁻²·nm⁻¹, with intravenous immunoglobulin (IVIG) 0.5 g/kg administered if bilirubin rises rapidly despite phototherapy, to prevent exchange transfusion and kernicterus 1
Immediate Phototherapy Initiation
- Intensive phototherapy should be started immediately when total serum bilirubin (TSB) exceeds age-specific thresholds for hemolytic disease, as Rh incompatibility creates a high-risk hemolytic profile requiring lower treatment thresholds than non-hemolytic jaundice 1, 2
Optimal Phototherapy Parameters
- Blue LED light sources with peak wavelength 460-490 nm (optimal at 478 nm) should be used, delivering irradiance ≥30 μW·cm⁻²·nm⁻¹ 3, 4
- Lights should be positioned 10-15 cm above the infant to maximize irradiance delivery 1
- Skin exposure should be maximized by removing all clothing except diaper and applying eye protection 1, 5
- The maximum body surface area should be illuminated using overhead devices with large footprints or circumferential (360°) systems 4, 6
- Irradiance levels should be verified with a calibrated spectral radiometer before and during treatment 3, 6
IVIG as Adjunctive Therapy
- IVIG 0.5 g/kg should be administered intravenously over 2-4 hours when bilirubin rises ≥0.5 mg/dL per hour despite phototherapy, as it significantly reduces exchange transfusion rates in Rh hemolytic disease 1
Monitoring Requirements
- Total serum bilirubin (TSB) should be measured within 4-24 hours after initiating phototherapy, depending on initial level and rate of rise 1
- Values should be plotted on hour-specific nomograms designed for hemolytic disease 1
- Patients should be monitored for signs of acute bilirubin encephalopathy, such as poor feeding, lethargy, high-pitched cry, and abnormal tone 5
- Hydration status should be assessed, and IV fluids should be provided if dehydration is present or oral intake is inadequate 1
Critical Safety Measures
- Phototherapy should not be interrupted until a documented bilirubin decrease occurs, then brief interruptions for feeding and bonding are acceptable 5, 7
- Eye masks should be used to prevent theoretical retinal damage, although human data are lacking 7
- Phototherapy does not exacerbate hemolysis 7
- Contraindications for phototherapy include congenital porphyria and photosensitizing drug exposure 5, 7